title: Use of Cough and Cold Medications in Severe Bronchiolitis before and after a Health Advisory Warning against Their Use.
abstract: We compared the use of cough and cold medications in 2 multicenter studies of young children hospitalized with bronchiolitis before and after the 2008 Food and Drug Administration cough and cold medications advisory. Although cough and cold medication use decreased after the advisory, nearly 20% of children age 12-23.9 months with severe bronchiolitis received cough and cold medications.
authors.affiliation: Division of General Pediatrics, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA. Electronic address: katherine.odonnell2@childrens.harvard.edu.
authors.forename: Katherine
authors.initials: K
authors.lastname: O'Donnell
authors.affiliation: Division of General Pediatrics, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Mansbach
authors.affiliation: Department of Emergency Medicine, Maricopa Medical Center, Phoenix, AZ.
authors.forename: Frank
authors.initials: F
authors.lastname: LoVecchio
authors.affiliation: Department of Pediatric Emergency Medicine, Children's Healthcare of Atlanta at Egleston, Atlanta, GA.
authors.forename: John
authors.initials: J
authors.lastname: Cheng
authors.affiliation: Departments of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX.
authors.forename: Pedro A
authors.initials: PA
authors.lastname: Piedra
authors.affiliation: Department of Emergency Medicine, Weill Cornell Medical College, New York, NY.
authors.forename: Sunday
authors.initials: S
authors.lastname: Clark
authors.affiliation: Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
authors.forename: Ashley F
authors.initials: AF
authors.lastname: Sullivan
authors.affiliation: Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Camargo
mesh_terms: D000367:Age Factors; D000996:Antitussive Agents / Q000008:administration & dosage / Q000009:adverse effects; D001988:Bronchiolitis / Q000188:drug therapy*; D003139:Common Cold / Q000188:drug therapy*; D003371:Cough / Q000188:drug therapy*; D005100:Expectorants / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009035:Mothers; D014663:Nasal Decongestants / Q000008:administration & dosage / Q000009:adverse effects; D004366:Nonprescription Drugs / Q000008:administration & dosage* / Q000009:adverse effects*; D011446:Prospective Studies; D056737:Safety-Based Drug Withdrawals; D012720:Severity of Illness Index; D012907:Smoking / Q000453:epidemiology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000996:Antitussive Agents; D005100:Expectorants; D014663:Nasal Decongestants; D004366:Nonprescription Drugs